首页 > 市场调查报告书 > 製药

生物製剂

市场调查报告书

商品编码

1459631

全球免疫球蛋白市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Immunoglobulins Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球免疫球蛋白市场需求预计将从 2023 年的 176.5 亿美元达到 2032 年近 325.3 亿美元的市场规模，2024-2032 年研究期间CAGR为 7.03%。

免疫球蛋白或抗体是免疫系统产生的蛋白质，用于识别和中和细菌、病毒和毒素等外来物质。它们透过与特定抗原结合并标记它们以被其他免疫细胞破坏，在人体防御感染和疾病方面发挥着至关重要的作用。免疫球蛋白分为不同的类别（IgM、IgG、IgA、IgD 和 IgE），每种类别都有独特的身体功能和分布。免疫球蛋白产生的缺陷或异常可能导致免疫失调并增加感染的易感性，这强调了维持健康的免疫系统的重要性。

市场动态

有几个因素推动了免疫球蛋白市场的发展，包括免疫缺陷疾病的日益流行、治疗和诊断用途的不断增长以及生物技术和蛋白质工程的进步。免疫球蛋白，也称为抗体，在免疫系统防御感染和疾病方面发挥着至关重要的作用，推动了对基于免疫球蛋白的疗法在治疗免疫缺陷性疾病、自体免疫疾病和传染病方面的需求。此外，越来越多地采用基于免疫球蛋白的诊断方法进行疾病筛检、监测和研究应用，进一步推动了市场的成长。此外，重组DNA技术和基因改造动物平台等生物製造技术的进步使得治疗性免疫球蛋白的生产具有更高的功效、安全性和可扩展性。此外，随着医疗保健提供者和患者寻求创新的治疗方案和诊断工具，新型免疫球蛋白疗法和诊断测定的监管批准和市场授权推动了市场扩张。然而，发展中地区获得医疗保健服务的机会有限、仿製药免疫球蛋白产品的定价压力以及产品审批方面的监管挑战可能会阻碍市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球免疫球蛋白市场的每个细分市场进行了包容性评估。免疫球蛋白产业的成长和趋势为本研究提供了整体方法。

市场区隔

免疫球蛋白市场报告的这一部分提供了国家和区域级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按申请

神经病学
免疫学
血液学
其他的

依给药途径

静脉
皮下
肌肉注射

按最终用户

医院
诊所
居家护理

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲免疫球蛋白市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。免疫球蛋白市场的主要参与者包括 Shire、CSL Behring、Kedrion Biopharma Inc.、Grifols, SA、Octapharma、China Biologic Products Holdings, Inc.、Biotest AG、Sanquin、LFB SA。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：免疫球蛋白公司的竞争格局

免疫球蛋白市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

公司股份分析
市场集中度
Shire

公司简介
公司收入
产品
最近的发展

CSL Behring

公司简介
公司收入
产品
最近的发展

Kedrion Biopharma Inc.

公司简介
公司收入
产品
最近的发展

Grifols SA

公司简介
公司收入
产品
最近的发展

Octapharma

公司简介
公司收入
产品
最近的发展

China Biologic Products Holdings Inc.

公司简介
公司收入
产品
最近的发展

Biotest AG

公司简介
公司收入
产品
最近的发展

Sanquin

公司简介
公司收入
产品
最近的发展

LFB SA

公司简介
公司收入
产品
最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

简介目录图表

Product Code: VMR112114030

The global demand for Immunoglobulins Market is presumed to reach the market size of nearly USD 32.53 Billion by 2032 from USD 17.65 Billion in 2023 with a CAGR of 7.03% under the study period 2024 - 2032.

Immunoglobulins or antibodies are proteins the immune system produces to identify and neutralize foreign substances such as bacteria, viruses, and toxins. They play a crucial role in the body's defense against infections and diseases by binding to specific antigens and marking them for destruction by other immune cells. Immunoglobulins are categorized into different classes (IgM, IgG, IgA, IgD, and IgE), each with unique bodily functions and distribution. Deficiencies or abnormalities in immunoglobulin production can lead to immune disorders and increase susceptibility to infections, emphasizing the significance of maintaining a healthy immune system.

MARKET DYNAMICS

Several factors drive the market for immunoglobulins, including the increasing prevalence of immunodeficiency disorders, growing applications in therapeutic and diagnostic uses, and advancements in biotechnology and protein engineering. Immunoglobulins, also known as antibodies, play a crucial role in the immune system's defense against infections and diseases, driving demand for immunoglobulin-based therapies in treating immunodeficiency disorders, autoimmune diseases, and infectious diseases. Additionally, the growing adoption of immunoglobulin-based diagnostics for disease screening, monitoring, and research applications further fuels market growth. Moreover, advancements in biomanufacturing technologies, such as recombinant DNA technology and transgenic animal platforms, enable the production of therapeutic immunoglobulins with improved efficacy, safety, and scalability. Furthermore, regulatory approvals and market authorizations for novel immunoglobulin therapies and diagnostic assays drive market expansion as healthcare providers and patients seek innovative treatment options and diagnostic tools. However, limited access to healthcare services in developing regions, pricing pressures from generic immunoglobulin products, and regulatory challenges in product approval are likely to hinder market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of immunoglobulins. The growth and trends of immunoglobulins industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the immunoglobulins market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Application

Neurology
Immunology
Hematology
Others

By Route Of Administration

Intravenous
Subcutaneous
Intramuscular

By End-User

Hospitals
Clinics
Homecare

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Immunoglobulins market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Immunoglobulins market include Shire, CSL Behring, Kedrion Biopharma Inc., Grifols, S.A., Octapharma, China Biologic Products Holdings, Inc., Biotest AG, Sanquin, LFB SA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . IMMUNOGLOBULINS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Application
- 3.7.2 Market Attractiveness Analysis By Route of Administration
- 3.7.3 Market Attractiveness Analysis By End-user
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY APPLICATION

5.1 Overview by Application
5.2 Historical and Forecast Data
5.3 Analysis by Application
5.4 Neurology Historic and Forecast Sales by Regions
5.5 Immunology Historic and Forecast Sales by Regions
5.6 Hematology Historic and Forecast Sales by Regions
5.7 Others Historic and Forecast Sales by Regions

6 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

6.1 Overview by Route of Administration
6.2 Historical and Forecast Data
6.3 Analysis by Route of Administration
6.4 Intravenous Historic and Forecast Sales by Regions
6.5 Subcutaneous Historic and Forecast Sales by Regions
6.6 Intramuscular Historic and Forecast Sales by Regions

7 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY END-USER

7.1 Overview by End-user
7.2 Historical and Forecast Data
7.3 Analysis by End-user
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Clinics Historic and Forecast Sales by Regions
7.6 Homecare Historic and Forecast Sales by Regions

8 . GLOBAL IMMUNOGLOBULINS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IMMUNOGLOBULINS COMPANIES

9.1. Immunoglobulins Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF IMMUNOGLOBULINS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. Shire
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. CSL Behring
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Kedrion Biopharma Inc.
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Grifols S.A.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Octapharma
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. China Biologic Products Holdings Inc.
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Biotest AG
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Sanquin
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. LFB SA
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments